Mahipal, Amit
Klapman, Jason
Vignesh, Shivakumar
Yang, Chung S.
Neuger, Anthony
Chen, Dung-Tsa
Malafa, Mokenge P.
Funding for this research was provided by:
National Cancer Institute (P3--CA-076292, R01-CA-129227)
Article History
Received: 1 October 2015
Accepted: 26 April 2016
First Online: 8 June 2016
Compliance with ethical standards
:
: Dr. Malafa is named as an inventor on the US Patent “Delta-Tocotrienol Treatment and Prevention of Pancreatic Cancer” (June 26, 2007; OTML docket number 06A069), but does not have financial interest in the companies that have licensed this patent. All other authors have no conflicts of interest to disclose.
: All participants provided written inform consent, and the study was conducted in accordance with the applicable guidelines on Good Clinical Practice.